| scholarly article | Q13442814 |
| P50 | author | Michael Green | Q89739732 |
| Camille Nelson Kotton | Q56379985 | ||
| P2093 | author name string | D Kumar | |
| M G Michaels | |||
| E A Blumberg | |||
| M I Morris | |||
| A Humar | |||
| M G Ison | |||
| S A Fischer | |||
| U Allen | |||
| AST Infectious Diseases Community of Practice and Transplant Infectious Diseases Section of TTS | |||
| P2860 | cites work | Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak | Q57099517 |
| Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans | Q22255463 | ||
| Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. | Q30380575 | ||
| Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. | Q30380578 | ||
| Response to a monovalent 2009 influenza A (H1N1) vaccine. | Q30380581 | ||
| The novel 2009 H1N1 influenza virus pandemic: unique considerations for programs in cardiothoracic transplantation. | Q30381902 | ||
| A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings | Q33908062 | ||
| Influenza virus infection in adult solid organ transplant recipients | Q40579386 | ||
| Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group | Q40625504 | ||
| Viral loads and duration of viral shedding in adult patients hospitalized with influenza. | Q43873120 | ||
| Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy | Q45115470 | ||
| Multiorgan distribution of human influenza A virus strains observed in a mouse model | Q45386851 | ||
| Pathology of Human Influenza A (H5N1) Virus Infection in Cynomolgus Macaques (Macaca fascicularis) | Q45723780 | ||
| Type A influenza: postmortem virus isolations from different organs in human lethal cases | Q45887945 | ||
| Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation. | Q46142983 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 18-25 | |
| P577 | publication date | 2009-12-02 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Guidance on novel influenza A/H1N1 in solid organ transplant recipients | |
| P478 | volume | 10 |
| Q30352359 | A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients. |
| Q30395254 | An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to [...] |
| Q30411233 | An outbreak of the 2009 influenza a (H1N1) virus in a children's hospital |
| Q30420230 | Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients |
| Q30410899 | Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives |
| Q30397634 | Challenges in the diagnosis of 2009 H1N1 in a lung transplant patient and the long-term implications for prevention and treatment: a case report. |
| Q39290443 | Clinical Characteristics and Outcomes of Influenza A Infection in Kidney Transplant Recipients: A Single-Center Experience |
| Q42219842 | Clinical features and outcomes of influenza infections in lung transplant recipients: a single-season cohort study |
| Q37867765 | Common infections in the lung transplant recipient |
| Q90067548 | Community-Acquired Respiratory Viruses in Transplant Patients: Diversity, Impact, Unmet Clinical Needs |
| Q30400403 | Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients |
| Q39529836 | Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial |
| Q30406140 | Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients |
| Q38058285 | Emerging viral diseases in kidney transplant recipients |
| Q51193296 | Humoral immune response following seasonal influenza vaccine in islet transplant recipients |
| Q30399281 | Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients |
| Q30403135 | Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix(®)) in renal transplant recipients. |
| Q30400161 | Immune response to pandemic H1N1 2009 influenza a vaccination in pediatric liver transplant recipients |
| Q38235003 | Immunization after kidney transplantation-what is necessary and what is safe? |
| Q38765363 | Immunization practices in solid organ transplant recipients |
| Q37320197 | Immunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review |
| Q39966481 | Impact of HIV on the severity of influenza |
| Q30372284 | Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients. |
| Q37866345 | Increased mortality of solid organ transplant recipients with H1N1 infection: a single center experience. |
| Q34993661 | Infections in liver transplant recipients. |
| Q30407134 | Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study |
| Q27011595 | Influenza prevention and treatment in transplant recipients and immunocompromised hosts |
| Q37940524 | Influenza vaccination in the organ transplant recipient: review and summary recommendations. |
| Q56765765 | Live viral vaccines in immunocompromised patients |
| Q38419551 | Live virus vaccines in transplantation: friend or foe? |
| Q43171412 | Liver transplantation in a patient acutely infected with pandemic influenza A H1N1. |
| Q30357871 | Low seroconversion after one dose of AS03-adjuvanted H1N1 pandemic influenza vaccine in solid-organ transplant recipients |
| Q38010486 | Lung transplant infection |
| Q30415267 | Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination |
| Q30374453 | New influenza A (H1N1/09) in three renal transplant patients |
| Q37555866 | Novel Influenza A (H1N1/09) Virus Infection during Pregnancy in a Kidney Transplant Recipient |
| Q37933515 | Novel influenza (H1N1) infection in pediatric renal transplant recipients: a single center experience. |
| Q39838350 | Oseltamivir‐resistant influenza A 2009 H1N1 virus in immunocompromised patients |
| Q30402383 | Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients |
| Q30391256 | Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study |
| Q30393274 | Pandemic (H1N1) 2009 Infection in Adult Solid Organ Transplant Recipients in Singapore |
| Q30394532 | Pandemic Influenza A/H1N1 Virus Infection in Solid Organ Transplant Recipients: A Multicenter Study |
| Q30405451 | Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination |
| Q30405250 | Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: impact of viral and non-viral co-infection |
| Q90085263 | Pediatric heart transplant from an incompletely treated influenza A-positive donor |
| Q30421507 | Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients. |
| Q37725208 | Prevention and treatment of infectious complications after solid organ transplantation in children |
| Q47912170 | Prevention and treatment of influenza illness: A seasonal challenge for transplant patients. |
| Q27334946 | Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets |
| Q26827388 | Prophylactic vaccinations in chronic kidney disease: Current status |
| Q38988696 | Respiratory Viruses: Influenza, RSV, and Adenovirus in Kidney Transplantation |
| Q42258364 | Respiratory distress syndrome caused by influenza H1N1 in a patient with a simultaneous pancreas-kidney transplantation. |
| Q26829188 | Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients |
| Q42272365 | Screening of donor and recipient in solid organ transplantation |
| Q33891744 | Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections |
| Q30413293 | Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients |
| Q30393896 | Successful salvage therapy with inhaled zanamivir in a patient with peramivir-resistant pandemic influenza A (H1N1) 2009 virus. |
| Q91784558 | The Oral Gonadotropin-releasing Hormone Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant Androgen Deprivation Therapy to External Beam Radiotherapy in Patients with Localised Intermediate-risk Prostate Cancer: A Randomised, Open-label, Parallel |
| Q30356534 | The effect of adjuvant H1N1 influenza vaccine on allograft kidney function. |
| Q30399407 | The impact of pandemic influenza A H1N1 2009 on Australian lung transplant recipients |
| Q30407550 | Transplantation of solid organs procured from influenza A H1N1 infected donors. |
| Q35705129 | Vaccination of oncology patients: an effective tool and an opportunity not to be missed |
| Q49745741 | XIth International Symposium on Respiratory Viral Infections |
| Q84947979 | [H1N1 (2009) influenza A infection in transplant recipient patients: a comparative study versus non-transplanted patients] |
Search more.